SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-15361"
 

Search: onr:"swepub:oai:DiVA.org:uu-15361" > Gene expression ana...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma

Schultz, Iman J (author)
Wester, Kenneth (author)
Uppsala universitet,Institutionen för genetik och patologi
Straatman, Huub (author)
show more...
Kiemeney, Lambertus A (author)
Babjuk, Marko (author)
Mares, Jaroslav (author)
Willems, Johannes L (author)
Swinkels, Dorine W (author)
Witjes, J Alfred (author)
Malmström, Per-Uno (author)
Uppsala universitet,Institutionen för kirurgiska vetenskaper,Urologi
de Kok, Jacques B (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2007
2007
English.
In: European Urology. - : Elsevier BV. - 0302-2838 .- 1873-7560. ; 51:2, s. 416-423
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objectives The individual recurrence-free period after primary surgery of patients with Ta urothelial cell carcinoma (UCC) cannot be predicted accurately. This study aims at discriminating between patients with primary Ta UCC and long or short recurrence-free periods. Methods We investigated mRNA expression of 23 genes in 44 primary Ta tumours (23 and 21 tumours were from patients with long [≥4 yr] or short [≤2 yr] recurrence-free periods, respectively), using real-time quantitative polymerase chain reaction. The genes were selected from previously published studies and showed a relationship with tumour recurrence in patients with UCC. Results Differential mRNA expression between the two patient groups indicated statistical significance only for the gene survivin (p = 0.0011). Its recurrence predictive value could not be increased by a combination with any of the other genes. Comparison of the receiver operating characteristic curves for survivin expression between patients with long or short recurrence-free intervals revealed an area under the curve of 0.79 (95%CI, 0.65–0.92). Using the median expression (0.84) as cut-off level, survivin identified 71.4% (95%CI, 47.8–88.7) and 69.6% (95%CI, 47.1–86.8) of the patients with long or short recurrence-free periods, respectively. Conclusions Our study identifies survivin as the most promising candidate to distinguish between patients with primary Ta UCC and long or short recurrence-free intervals. Therefore, survivin mRNA expression analysis might help the urologist to individualise patient treatment and prevent unnecessary cystoscopies in a subgroup of these patients.

Keyword

Adult
Aged
Aged; 80 and over
Carcinoma; Transitional Cell/*genetics/*surgery
Female
Gene Expression Profiling
Humans
Male
Middle Aged
Neoplasm Recurrence; Local/*genetics
Predictive Value of Tests
RNA; Neoplasm/biosynthesis
Urinary Bladder Neoplasms/*genetics/*surgery
MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view